PTC Therapeutics, Inc.
PTCT· Nasdaq
Released Feb 27, 2025, after the close
10-K filed Feb 27, 2025, 58 days after period end · 0001070081-25-000012
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $213.17M | $307.06M | $167.41M | $165.23M |
| Net Income | -$65.89M |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| -$155.79M |
| -$170.89M |
| -$143.27M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.